​

Zoetis (ZTS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ZTS Stock Forecast

Zoetis (ZTS) stock forecast, based on 32 Wall Street analysts, predicts a 12-month average price target of $84.75, with a high of $95.00 and a low of $74.00. This represents a 2.64% increase from the last price of $82.57.

$65 $78 $91 $104 $117 $130 High: $95 Avg: $84.75 Low: $74 Last Closed Price: $82.57

ZTS Stock Rating

Zoetis stock's rating consensus is Hold, based on 32 Wall Street analysts. The breakdown includes 1 Strong Buy (3.12%), 13 Buy (40.62%), 18 Hold (56.25%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 32 18 13 1 Strong Sell Sell Hold Buy Strong Buy

ZTS Price Target Upside V Benchmarks

TypeNameUpside
StockZoetis2.64%
SectorHealthcare Stocks 15.45%
IndustrySpecialty & Generic Drug Manufacturers Stocks14.61%

Price Target Trends

1M3M12M
# Anlaysts3522
Avg Price Target$79.67$82.60$107.18
Last Closing Price$82.57$82.57$82.57
Upside/Downside-3.51%0.04%29.81%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Nov, 263211--16
Oct, 26449--17
Sep, 26459--18
Aug, 26389--20
Jul, 26389--20
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 29, 2026Morgan Stanley$82.00$77.865.32%-0.69%
Oct 20, 2026Keith DevasJefferies$83.00$79.594.28%0.52%
Oct 16, 2026Goldman Sachs$74.00$78.42-5.64%-10.38%
Aug 25, 2026Cantor Fitzgerald$94.00$77.1721.81%13.84%
Aug 20, 2026Jonathan BlockStifel Nicolaus$80.00$76.684.33%-3.11%
Aug 07, 2026Morgan Stanley$85.00$75.3012.88%2.94%
Jul 27, 2026UBS$85.00$76.5211.08%2.94%
Jul 22, 2026Morgan Stanley$99.00$75.5031.13%19.90%
Jul 06, 2026HSBC$95.00$74.6327.29%15.05%
Jul 01, 2026Barclays$85.00$71.9118.20%2.94%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 27, 2026UBSNeutralNeutralhold
Oct 20, 2026JefferiesHolddowngrade
Oct 16, 2026Goldman SachsBuyNeutralinitialise
Aug 25, 2026Cowen & Co.BuyBuyhold
Aug 06, 2026William BlairOutperformMarket Performdowngrade
May 15, 2026Morgan StanleyOverweightOverweighthold
Apr 15, 2026CitigroupBuyinitialise
Mar 10, 2026Leerink PartnersMarket PerformMarket Performhold
Mar 02, 2026William BlairOutperformOutperformhold
Feb 26, 2026BTIGBuyBuyhold

Financial Forecast

EPS Forecast

$4 $5 $6 $7 $8 $9 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$4.29$4.51$5.08$5.47$6.03---
Avg Forecast$4.67$4.88$5.41$5.89$6.36$7.06$7.90$8.55
High Forecast$4.75$4.99$5.43$5.93$6.50$7.42$8.11$8.81
Low Forecast$4.59$4.77$5.39$5.88$6.20$6.37$7.51$8.26
Surprise %-8.14%-7.58%-6.10%-7.13%-5.19%---

Revenue Forecast

$8B $8B $9B $10B $11B $12B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$7.78B$8.08B$8.54B$9.26B$9.47B---
Avg Forecast$7.74B$8.04B$8.52B$9.26B$9.66B$10.33B$11.03B$11.44B
High Forecast$7.85B$8.18B$8.54B$9.27B$9.83B$10.35B$11.03B$11.71B
Low Forecast$7.65B$7.90B$8.50B$9.23B$9.45B$10.31B$11.03B$11.14B
Surprise %0.42%0.47%0.25%-0.05%-2.02%---

Net Income Forecast

$1B $2B $2B $3B $4B $5B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.04B$2.11B$2.34B$2.49B$2.67B---
Avg Forecast$1.77B$2.01B$2.34B$2.73B$2.94B$3.05B$3.61B$3.95B
High Forecast$2.12B$2.42B$2.81B$2.74B$3.01B$3.43B$3.75B$4.07B
Low Forecast$1.41B$1.61B$1.88B$2.72B$2.87B$2.94B$3.47B$3.82B
Surprise %15.25%5.02%--8.87%-8.99%---

ZTS Forecast FAQ

Is Zoetis stock a buy?

Zoetis stock has a consensus rating of Hold, based on 32 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 13 Buy, 18 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Zoetis is a neutral investment for most analysts.

What is Zoetis's price target?

Zoetis's price target, set by 32 Wall Street analysts, averages $84.75 over the next 12 months. The price target range spans from $74 at the low end to $95 at the high end, suggesting a potential 2.64% change from the previous closing price of $82.57.

How does Zoetis stock forecast compare to its benchmarks?

Zoetis's stock forecast shows a 2.64% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the specialty & generic drug manufacturers stocks industry (14.61%).

What is the breakdown of analyst ratings for Zoetis over the past three months?

  • November 2026: 18.75% Strong Buy, 12.50% Buy, 68.75% Hold, 0% Sell, 0% Strong Sell.
  • October 2026: 23.53% Strong Buy, 23.53% Buy, 52.94% Hold, 0% Sell, 0% Strong Sell.
  • September 2026: 22.22% Strong Buy, 27.78% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.

What is Zoetis’s EPS forecast?

Zoetis's average annual EPS forecast for its fiscal year ending in December 2026 is $7.06, marking a 17.08% increase from the reported $6.03 in 2025. Estimates for the following years are $7.9 in 2027, and $8.55 in 2028.

What is Zoetis’s revenue forecast?

Zoetis's average annual revenue forecast for its fiscal year ending in December 2026 is $10.33B, reflecting a 9.09% increase from the reported $9.47B in 2025. The forecast for 2027 is $11.03B, and $11.44B for 2028.

What is Zoetis’s net income forecast?

Zoetis's net income forecast for the fiscal year ending in December 2026 stands at $3.05B, representing an 13.94% increase from the reported $2.67B in 2025. Projections indicate $3.61B in 2027, and $3.95B in 2028.